Kahira Pharmaceuticals & Chemical Industries Company (EGX:CPCI)
Egypt
· Delayed Price · Currency is EGP 273.88
+4.57 (1.70%)
At close: Dec 4, 2025
EGX:CPCI Balance Sheet
Financials in millions EGP. Fiscal year is July - June.
Millions EGP. Fiscal year is Jul - Jun.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2016 - 2020 |
| Cash & Equivalents | 171.22 | 168.28 | 139.38 | 111.87 | 131.76 | Upgrade
|
| Short-Term Investments | - | - | - | - | 15 | Upgrade
|
| Cash & Short-Term Investments | 171.22 | 168.28 | 139.38 | 111.87 | 146.76 | Upgrade
|
| Cash Growth | 1.74% | 20.73% | 24.59% | -23.77% | 78.17% | Upgrade
|
| Accounts Receivable | 554.09 | 320.85 | 328.89 | 427.53 | 440.54 | Upgrade
|
| Other Receivables | 52.48 | 58.7 | 0.35 | 50.33 | 45.53 | Upgrade
|
| Receivables | 625.83 | 392.07 | 356.8 | 509.83 | 487.47 | Upgrade
|
| Inventory | 591.46 | 465.59 | 401.77 | 333.41 | 281.22 | Upgrade
|
| Prepaid Expenses | 3.8 | 0.26 | 0.25 | - | - | Upgrade
|
| Other Current Assets | 66.69 | 30.89 | 89.72 | - | - | Upgrade
|
| Total Current Assets | 1,459 | 1,057 | 987.92 | 955.11 | 915.46 | Upgrade
|
| Property, Plant & Equipment | 562.56 | 453.82 | 249.24 | 211.12 | 150.41 | Upgrade
|
| Long-Term Investments | 4.93 | 4.16 | 2.6 | 2.6 | 2.6 | Upgrade
|
| Other Intangible Assets | 0.01 | 0.03 | 0.04 | 0.06 | - | Upgrade
|
| Other Long-Term Assets | - | 0 | - | - | - | Upgrade
|
| Total Assets | 2,026 | 1,515 | 1,240 | 1,169 | 1,068 | Upgrade
|
| Accounts Payable | 435.55 | 237.1 | 224.39 | 142.9 | 235.93 | Upgrade
|
| Accrued Expenses | 19.06 | 20.18 | 14.42 | - | - | Upgrade
|
| Short-Term Debt | 22.99 | - | 56.66 | - | - | Upgrade
|
| Current Portion of Long-Term Debt | 40 | 36.67 | - | - | - | Upgrade
|
| Current Income Taxes Payable | 120.14 | 61.62 | 29.36 | 48.13 | 38.2 | Upgrade
|
| Other Current Liabilities | 160.19 | 113.68 | 122.19 | 118.76 | 84.03 | Upgrade
|
| Total Current Liabilities | 797.91 | 469.25 | 447.02 | 309.8 | 358.16 | Upgrade
|
| Long-Term Debt | 123.33 | 163.33 | 68.76 | - | - | Upgrade
|
| Long-Term Leases | 35.46 | 37.53 | 38.85 | 58.36 | - | Upgrade
|
| Long-Term Deferred Tax Liabilities | 23.28 | 12.49 | 4.87 | 6.8 | 6.58 | Upgrade
|
| Other Long-Term Liabilities | 0 | 0 | - | - | - | Upgrade
|
| Total Liabilities | 979.99 | 682.6 | 559.5 | 374.95 | 364.74 | Upgrade
|
| Common Stock | 149.34 | 149.34 | 149.34 | 149.34 | 149.34 | Upgrade
|
| Retained Earnings | 757.84 | 543.76 | 383.26 | 488.51 | 398.33 | Upgrade
|
| Comprehensive Income & Other | 139.32 | 139.39 | 147.7 | 156.09 | 156.06 | Upgrade
|
| Shareholders' Equity | 1,047 | 832.49 | 680.31 | 793.94 | 703.73 | Upgrade
|
| Total Liabilities & Equity | 2,026 | 1,515 | 1,240 | 1,169 | 1,068 | Upgrade
|
| Total Debt | 221.78 | 237.53 | 164.27 | 58.36 | - | Upgrade
|
| Net Cash (Debt) | -50.57 | -69.25 | -24.88 | 53.52 | 146.76 | Upgrade
|
| Net Cash Growth | - | - | - | -63.53% | 79.29% | Upgrade
|
| Net Cash Per Share | -3.39 | -4.64 | -1.67 | 3.58 | 9.83 | Upgrade
|
| Filing Date Shares Outstanding | 14.93 | 14.93 | 14.93 | 14.93 | 14.93 | Upgrade
|
| Total Common Shares Outstanding | 14.93 | 14.93 | 14.93 | 14.93 | 14.93 | Upgrade
|
| Working Capital | 661.08 | 587.84 | 540.89 | 645.31 | 557.29 | Upgrade
|
| Book Value Per Share | 70.07 | 55.74 | 45.55 | 53.16 | 47.12 | Upgrade
|
| Tangible Book Value | 1,046 | 832.46 | 680.26 | 793.88 | 703.73 | Upgrade
|
| Tangible Book Value Per Share | 70.07 | 55.74 | 45.55 | 53.16 | 47.12 | Upgrade
|
| Land | 0.4 | - | 0.4 | 0.4 | 0.4 | Upgrade
|
| Buildings | 151.31 | - | 53.43 | 53.42 | 51.12 | Upgrade
|
| Machinery | 545.75 | - | 291.46 | 250.9 | 244.46 | Upgrade
|
| Construction In Progress | 128.61 | 212.7 | 114.11 | 81.88 | 75.24 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.